National Research Corporation
NRC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.01 | -20.06 | -2.26 | -41.70 |
| FCF Yield | 4.58% | 2.30% | 2.84% | 3.87% |
| EV / EBITDA | 11.55 | 21.81 | 17.88 | 18.14 |
| Quality | ||||
| ROIC | 26.15% | 33.00% | 33.77% | 31.65% |
| Gross Margin | 60.20% | 62.30% | 62.36% | 64.62% |
| Cash Conversion Ratio | 1.40 | 1.23 | 1.14 | 1.24 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.91% | 0.14% | 4.38% | 4.95% |
| Free Cash Flow Growth | -14.14% | -15.50% | -35.27% | 11.40% |
| Safety | ||||
| Net Debt / EBITDA | 1.42 | 0.70 | -0.05 | -0.49 |
| Interest Coverage | 13.56 | 46.46 | 38.50 | 30.16 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 20.91 | 22.33 | 29.21 | 20.56 |